| RS1560002147 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Renal-hepatic-pancreatic dysplasia 1 |
| RS1560002959 |
ARL13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 8, Joubert syndrome |
| RS1560014115 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
NPHP3-related Meckel-like syndrome, Nephronophthisis 3 |
| RS1560014265 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1560017341 |
SI
|
Health Risk |
Likely pathogenic |
— |
| RS1560017690 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1560017781 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS1560026402 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560031341 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1560033414 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1560033613 |
ATP2C1
|
Health Risk |
Pathogenic |
Familial benign pemphigus, Familial benign pemphigus |
| RS1560034617 |
POGLUT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2R1, Autosomal recessive limb-girdle muscular dystrophy type 2R1 |
| RS1560035336 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS1560040369 |
DNAJC19
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 5, 3-methylglutaconic aciduria type 5 |
| RS1560041195 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1560045738 |
P2RY12
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 8, Platelet-type bleeding disorder 8 |
| RS1560046529 |
TTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560046837 |
RHO
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 4, Retinal dystrophy |
| RS1560046845 |
RHO
|
Health Risk |
Pathogenic |
Neuropathy, congenital hypomyelinating |
| RS1560062082 |
STAG1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS1560063136 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, Pierson syndrome |
| RS1560066873 |
LAMB2
|
Health Risk |
Pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, Pierson syndrome |
| RS1560069336 |
MED12L
|
Health Risk |
Likely pathogenic |
Nizon-Isidor syndrome, Nizon-Isidor syndrome |
| RS1560070780 |
PLS1
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing loss |
| RS1560072794 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, Pierson syndrome |
| RS1560075787 |
LAMB2
|
Health Risk |
Pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS1560075930 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS1560079213 |
CCDC39
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1560082927 |
ATP13A3
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension, Pulmonary hypertension |
| RS1560086701 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Heterotaxy |
| RS1560090006 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1560092083 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560092160 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1560092224 |
ZBTB20
|
Health Risk |
Pathogenic |
Clinodactyly of the 4th toe, Moderate global developmental delay |
| RS1560092440 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1560092633 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS1560092712 |
CCDC39
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1560098548 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Pierpont syndrome, Pierpont syndrome |
| RS1560102245 |
ZNF148
|
Health Risk |
Likely pathogenic |
— |
| RS1560103306 |
MED12L
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1560106851 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560108090 |
MED12L
|
Health Risk |
Pathogenic |
Intellectual disability, Nizon-Isidor syndrome |
| RS1560108537 |
EIF2B5
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 5 |
| RS1560110565 |
ZBTB20
|
Health Risk |
Pathogenic |
Primrose syndrome, Primrose syndrome |
| RS1560113283 |
TREX1
|
Health Risk |
Pathogenic |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS1560115921 |
MED12L
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1560117033 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
— |
| RS1560118923 |
MECOM
|
Health Risk |
Pathogenic |
— |
| RS1560120302 |
RPL35A
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 5, Diamond-Blackfan anemia |
| RS1560121645 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Curry-Hall syndrome |
| RS1560121685 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1560122302 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1560126707 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560127636 |
IFT57
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome 18, Orofaciodigital syndrome 18 |
| RS1560134806 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1560135485 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1560137208 |
PIK3CA
|
Health Risk |
Pathogenic |
CLAPO syndrome, CLAPO syndrome |
| RS1560137609 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, PIK3CA related overgrowth syndrome |
| RS1560141393 |
RAB28
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 18, Cone-rod dystrophy 18 |
| RS1560161567 |
ALG3
|
Health Risk |
Pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS1560162116 |
ALG3
|
Health Risk |
Pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS1560164682 |
ALG3
|
Health Risk |
Likely pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS1560165127 |
NKX3-2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondylo-megaepiphyseal-metaphyseal dysplasia, Spondylo-megaepiphyseal-metaphyseal dysplasia |
| RS1560166488 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1560166511 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 6 |
| RS1560166870 |
ALG3
|
Health Risk |
Pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS1560171734 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1560171992 |
MRAS
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS1560172761 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560177950 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1560180188 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1560180583 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560184664 |
CC2D2A
|
Health Risk |
Likely pathogenic |
COACH syndrome 1, Joubert syndrome 9 |
| RS1560187743 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1560188288 |
CC2D2A
|
Health Risk |
Pathogenic |
— |
| RS1560196405 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1560196436 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1560199860 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1560200657 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1560200925 |
DOK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1560204600 |
COL7A1
|
Health Risk |
Pathogenic |
COL7A1-related disorder, Recessive dystrophic epidermolysis bullosa |
| RS1560204773 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS1560206805 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1560208675 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1560210381 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1560212751 |
DOCK3
|
Health Risk |
Likely pathogenic |
Hypotonia, Global developmental delay |
| RS1560219171 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1560224024 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, MCCC1-related disorder |
| RS1560224831 |
DOK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS1560231816 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1560232515 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Transient bullous dermolysis of the newborn, 7 conditions |
| RS1560234201 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1560237346 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
7 conditions, 7 conditions |
| RS1560241522 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS1560243788 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1560245772 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1560255134 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1560255926 |
MASP1
|
Health Risk |
Pathogenic |
3MC syndrome 1, 3MC syndrome 1 |
| RS1560255987 |
CLCN2
|
Health Risk |
Pathogenic |
— |
| RS1560256569 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |